Arkolith/Insider Trading/REPH/Form 4

Lake Ryan David

Chief Financial OfficerRecro Pharma, Inc. (REPH) · full profile →Form 4 · filed Jun 8, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 7, 2021Tax withholding(F)719$2.30$2K378K
Jun 5, 2021Option exercise(M)3K——379K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 5, 2021Option exercise(M)3K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001192482-21-000496) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML